These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Microdoses of BCG vaccine in the treatment of cancer]. Rivera P; Caffarena E; Cornejo H; Fonerón A; Haemersli J; del Pino M; Sepúlveda M; Ubilla A Rev Med Chil; 1992 Jun; 120(6):700-1. PubMed ID: 1341807 [No Abstract] [Full Text] [Related]
29. Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview. van der Meijden AP; Debruyne FM; Steerenberg PA; de Jong WH Prog Clin Biol Res; 1989; 310():11-33. PubMed ID: 2672011 [No Abstract] [Full Text] [Related]
32. Risk-adapted use of intravesical chemotherapy. Lerner SP; Au JL BJU Int; 2008 Nov; 102(9 Pt B):1247-53. PubMed ID: 19035889 [No Abstract] [Full Text] [Related]
33. [Place of endovesical "BCG Therapy" in superficial tumors of the bladder]. Zerbib M J Urol (Paris); 1995; 101(2):59-63. PubMed ID: 8522855 [TBL] [Abstract][Full Text] [Related]
34. BCG therapy for superficial bladder cancer: fundamental aspects. Hudson ML; Ratliff TL In Vivo; 1991; 5(6):643-6. PubMed ID: 1810450 [No Abstract] [Full Text] [Related]
35. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer. Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662 [No Abstract] [Full Text] [Related]
36. Intravesical and intradermal BCG-RIVM application: a toxicity study. Debruyne FM; van der Meijden AP; Schreinemachers LM; Wagenaar J; Feitz WF; Hendriks B; de Jong WH; Steeren-Berg PA Prog Clin Biol Res; 1985; 185B():151-9. PubMed ID: 4034587 [No Abstract] [Full Text] [Related]
37. BCG in the treatment of bladder cancer: state of the art. Morales A Prog Clin Biol Res; 1989; 310():3-10. PubMed ID: 2672017 [No Abstract] [Full Text] [Related]
38. [A comparative study of BCG and mitomycin C in superficial carcinomas of the bladder]. Iavarone C; Minocchi L; Arecchi S; Nicolucci D; Porcelli C; D'orazi V; Greco L; Stio F; Martino G; Messinetti S G Chir; 1996 May; 17(5):289-91. PubMed ID: 8755233 [No Abstract] [Full Text] [Related]
39. Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Lamm DL Clin Infect Dis; 2000 Sep; 31 Suppl 3():S86-90. PubMed ID: 11010830 [TBL] [Abstract][Full Text] [Related]
40. [Treatment and follow-up of superficial bladder cancer]. Raitanen M Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]